Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 2;93(4):2627-2634.
doi: 10.1021/acs.analchem.0c04779. Epub 2021 Jan 20.

Suitcase Lab for Rapid Detection of SARS-CoV-2 Based on Recombinase Polymerase Amplification Assay

Affiliations

Suitcase Lab for Rapid Detection of SARS-CoV-2 Based on Recombinase Polymerase Amplification Assay

Ahmed Abd El Wahed et al. Anal Chem. .

Abstract

In March 2020, the SARS-CoV-2 virus outbreak was declared as a world pandemic by the World Health Organization (WHO). The only measures for controlling the outbreak are testing and isolation of infected cases. Molecular real-time polymerase chain reaction (PCR) assays are very sensitive but require highly equipped laboratories and well-trained personnel. In this study, a rapid point-of-need detection method was developed to detect the RNA-dependent RNA polymerase (RdRP), envelope protein (E), and nucleocapsid protein (N) genes of SARS-CoV-2 based on the reverse transcription recombinase polymerase amplification (RT-RPA) assay. RdRP, E, and N RT-RPA assays required approximately 15 min to amplify 2, 15, and 15 RNA molecules of molecular standard/reaction, respectively. RdRP and E RT-RPA assays detected SARS-CoV-1 and 2 genomic RNA, whereas the N RT-RPA assay identified only SARS-CoV-2 RNA. All established assays did not cross-react with nucleic acids of other respiratory pathogens. The RT-RPA assay's clinical sensitivity and specificity in comparison to real-time RT-PCR (n = 36) were 94 and 100% for RdRP; 65 and 77% for E; and 83 and 94% for the N RT-RPA assay. The assays were deployed to the field, where the RdRP RT-RPA assays confirmed to produce the most accurate results in three different laboratories in Africa (n = 89). The RPA assays were run in a mobile suitcase laboratory to facilitate the deployment at point of need. The assays can contribute to speed up the control measures as well as assist in the detection of COVID-19 cases in low-resource settings.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following competing financial interest(s): All authors except Marco Kaiser and Olfert Landt are in the public research sector. Mentioned authors are employed by GenExpress and/or Tib MolBiol, manufacturer of molecular standard or oligonucleotides. This does not alter the authors adherence to all the scientific policies on sharing data and materials.

Figures

Figure 1
Figure 1
Probit regression analysis for RdRP, E, and N RT-RPA assays. The limit of detection in 95% of cases is two RNA molecules/reaction for the RdRP RT-RPA assay (red) and 15 RNA molecules per reaction each for E and N RT-RPA assays (black).
Figure 2
Figure 2
Results of 36 clinical samples analyzed with real-time RT-PCR for the E gene and RT-RPA assays for the RdRP, E, and N genes. CT is the cycle threshold, and TT is the threshold time. The red dot represents the real-time RT-PCR sample not detected by the RdRP RT-RPA, and the horizontal red lines indicate the median of TT or CT values.

Similar articles

Cited by

References

    1. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020, 5, 536–544. 10.1038/s41564-020-0695-z. - DOI - PMC - PubMed
    1. WHO. WHO announces COVID-19 outbreak apandemic. https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus... (accessed June 25, 2020).
    1. Li R.; Pei S.; Chen B.; Song Y.; Zhang T.; Yang W.; Shaman J. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science 2020, 368, 489–493. 10.1126/science.abb3221. - DOI - PMC - PubMed
    1. Leung C. C.; Cheng K. K.; Lam T. H.; Migliori G. B. Mask wearing to complement social distancing and save lives during COVID-19. Int. J. Tuberc. Lung Dis. 2020, 24, 556–558. 10.5588/ijtld.20.0244. - DOI - PubMed
    1. Corman V. M.; Landt O.; Kaiser M.; Molenkamp R.; Meijer A.; Chu D. K.; Bleicker T.; Brunink S.; Schneider J.; Schmidt M. L.; Mulders D. G.; Haagmans B. L.; van der Veer B.; van den Brink S.; Wijsman L.; Goderski G.; Romette J. L.; Ellis J.; Zambon M.; Peiris M.; Goossens H.; Reusken C.; Koopmans M. P.; Drosten C. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance 2020, 25, 200004510.2807/1560-7917.ES.2020.25.3.2000045. - DOI - PMC - PubMed

Publication types

MeSH terms